> Design Issues in Drug Development
>
> 10 April 2002
>
> a one-day scientific meeting organised by
> Statisticians in the Pharmaceutical Industry (PSI)
>
> Venue:
> RSA Durham St Auditorium
> Durham House St
> Off The Strand
> London WC2N 6EZ
>
> Agenda:
> 09.15 - 9.45 Registration
>
> 09.45 Opening Remarks
>
> 9.50 - 10.30 Trupti Trivedi, (GlaxoSmithKline)
> Factors for Consideration in the Design of Antiviral Programs
>
> 10.30 - 11.10 Peter Colman, (Pfizer)
> Partially Balanced Incomplete Block Designs in Clinical
> Pharmacology.
>
> 11.10 - 11.35 Coffee
>
> 11.35 - 12.15 Prof. Peter W. Jones, (Keele University)
> Evaluation of Adaptive Designs.
>
> 12.15 - 13.20 Lunch
>
> 13.20 - 14.00 Prof. John Whitehead and Dr Yinghui Zhou, (Reading
> University)
> Bayesian Procedures for Dose-Escalation
> in Phase I Clinical Trials
>
> 14.00 - 14.40 Dr Nigel Stallard, (Reading University)
> A Decision-Theoretic Approach for Phase II Clinical Trials
> with Multiple Endpoints
>
> 14.40 - 15.00 Tea
>
> 15.00 - 15.40 Rob Hemmings, (Medicines Control
> Agency)
> A Single Answer to a Multiplicity of Problems?
>
> 15.40 - 16.20 Paul Silcocks, (PAREXEL)
> Epidemiology in Drug Development
>
> 16.20 Meeting Close
>
> Registration:
> PSI Members
> £176.25 (inc. £26.25 VAT)
> Non-Members
> £188.00 (inc £28.00 VAT)
> Fee includes lunch, refreshments and VAT
>
> For further details please contact:
> Lynn Devall.
> Tel: +44 (0)1625 511750
> Fax: +44 (0)1625 267879
> [log in to unmask]
>
|